VYNE Therapeutics Inc. (VYNE): SCHEDULE 13G filed May 15, 2026

Form type

SCHEDULE 13G

Filing date

May 15, 2026

Accession number

0001104659-26-062664

Filer

VYNE Therapeutics Inc. (CIK 1566044)